# Bambu Capital

Bambu Capital is an Asset Manager based in New York, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** New York, United States
- **Region:** North America
- **Address:** New York, NY, United States
- **Assets under management:** Undisclosed
- **Website:** bambu-capital.com
- **LinkedIn:** https://www.linkedin.com/company/bambumeta

## About

Bambu Capital is an operator-led private equity firm that partners with founder-led, tech-enabled services businesses in the lower middle-market. The firm brings hands-on operating leadership, institutional systems, and AI-enabled discipline to transform proven companies into scalable, institutional-grade platforms. Its current portfolio includes Lemonaid Health, a telemedicine company acquired out of the 23andMe bankruptcy.

## Sectors

- Digital Health
- Enterprise Software

## Questions

### What is BambuMeta's investment strategy?

BambuMeta, operating through Bambu Capital, focuses on majority acquisitions of tech-enabled businesses and executing operational turnarounds to drive growth and profitability. The firm takes a concentrated, hands-on approach rather than adding value through passive minority positions.

### Can you detail a representative deal for BambuMeta?

The firm established a special purpose vehicle to acquire Lemonaid Health, a digital health platform. Post-acquisition, BambuMeta reported a revenue expansion of over 20% and guided the company to profitability within six months, serving as a template for its operational playbook.

### How does BambuMeta structure its investments?

BambuMeta uses special purpose vehicles, as evidenced in the Lemonaid Health acquisition. This structure allows for flexible capital formation on a deal-by-deal basis, distinct from a traditional commingled fund model with a fixed investment period.

### Who runs investment decisions at BambuMeta?

While the firm describes its team as operators with decades of experience, specific names and titles for the investment committee or managing partners are not publicly disclosed in its current materials.

## Related profiles

- [Pinchin](https://altss.com/profile/pinchin-ltd)
- [Dechra Pharmaceuticals](https://altss.com/profile/dechra-pharmaceuticals-plc)

---

Last updated: 2026-07-10T20:15:06.000Z

Canonical page: https://altss.com/profile/bambumeta

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology